Drug Trial Radar · NCT04293562
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,400
Planned (sponsor's estimate)
Start
Jul 21, 2020
Primary completion
Jun 30, 2029
Study completion Jun 30, 2029
Sponsor
- Lead sponsor
- Children's Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Mar 3, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial compares standard chemotherapy to therapy with liposome-encapsulated daunorubicin-cytarabine (CPX-351) and/or gilteritinib for patients with newly diagnosed acute myeloid leukemia with or without FLT3 mutations. Drugs used in chemotherapy, such as daunorubicin, cytarabine, and gemtuzumab ozogamicin, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. CPX-351 is made up of daunorubicin and cytarabine and is made in a way that makes the drugs stay in the bone marrow longer and could be less likely to cause heart problems than traditional anthracycline drugs, a common class of chemotherapy drug. Some acute myeloid leukemia patients have an abnormality in the structure of a gene called FLT3. Genes are pieces of DNA (molecules that carry instructions for development, functioning, growth and reproduction) inside each cell that tell the cell what to do and when to grow and divide. FLT3 plays an important role in the normal making of blood cells. This gene can have permanent changes that cause it to function abnormally by making cancer cells grow. Gilteritinib may block the abnormal function of the FLT3 gene that makes cancer cells grow. The overall goals of this study are, 1) to compare the effects, good and/or bad, of CPX-351 with daunorubicin and cytarabine on people with newly diagnosed AML to find out which is better, 2) to study the effects, good and/or bad, of adding gilteritinib to AML therapy for patients with high amounts of FLT3/ITD or other FLT3 mutations and 3) to study changes in heart function during and after treatment for AML. Giving CPX-351 and/or gilteritinib with standard chemotherapy may work better in treating patients with acute myeloid leukemia compared to standard chemotherapy alone.
Conditions
- Acute Myeloid Leukemia
Interventions
Allogeneic Hematopoietic Stem Cell TransplantationProcedure
Undergo allogeneic HSCT
Asparaginase Erwinia chrysanthemiDrug
Given IM or IV
Biospecimen CollectionProcedure
Undergo blood sample collection
Bone Marrow AspirationProcedure
Undergo BM aspiration
Bone Marrow BiopsyProcedure
BM biopsy
Computed TomographyProcedure
Undergo CT
CytarabineDrug
Given IV or IT
Daunorubicin HydrochlorideDrug
Given IV
Dexrazoxane HydrochlorideDrug
Given IV
EtoposideDrug
Given IV
Fludeoxyglucose F-18Other
Undergo FDG-PET
Gemtuzumab OzogamicinDrug
Given IV
Gilteritinib FumarateDrug
Given PO/NG/G-tube
Liposome-encapsulated Daunorubicin-CytarabineDrug
Given IV
Magnetic Resonance ImagingProcedure
Undergo MRI
MethotrexateDrug
Given IT
Mitoxantrone HydrochlorideDrug
Given IV
Positron Emission TomographyProcedure
Undergo FDG-PET
Questionnaire AdministrationOther
Ancillary studies
Therapeutic HydrocortisoneDrug
Given IT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event-free survival (EFS)Time frame: Up to 3 years
Locations
206 sites in 4 countries. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama · Recruiting
USA Health Strada Patient Care Center
Mobile, Alabama · Recruiting
Banner Children's at Desert
Mesa, Arizona · Recruiting
Phoenix Childrens Hospital
Phoenix, Arizona · Recruiting
Banner University Medical Center - Tucson
Tucson, Arizona · Recruiting
Arkansas Children's Hospital
Little Rock, Arkansas · Recruiting
Kaiser Permanente Downey Medical Center
Downey, California · Recruiting
City of Hope Comprehensive Cancer Center
Duarte, California · Recruiting
Loma Linda University Medical Center
Loma Linda, California · Recruiting
Miller Children's and Women's Hospital Long Beach
Long Beach, California · Recruiting
Children's Hospital Los Angeles
Los Angeles, California · Recruiting
Cedars-Sinai Medical Center
Los Angeles, California · Recruiting
Mattel Children's Hospital UCLA
Los Angeles, California · Recruiting
Valley Children's Hospital
Madera, California · Recruiting
UCSF Benioff Children's Hospital Oakland
Oakland, California · Recruiting
Kaiser Permanente-Oakland
Oakland, California · Recruiting
Children's Hospital of Orange County
Orange, California · Recruiting
Lucile Packard Children's Hospital Stanford University
Palo Alto, California · Recruiting
University of California Davis Comprehensive Cancer Center
Sacramento, California · Recruiting
Rady Children's Hospital - San Diego
San Diego, California · Recruiting
UCSF Medical Center-Mission Bay
San Francisco, California · Recruiting
Santa Barbara Cottage Hospital
Santa Barbara, California · Recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
Denver, Colorado · Recruiting
Connecticut Children's Medical Center
Hartford, Connecticut · Recruiting
Yale University
New Haven, Connecticut · Recruiting
Alfred I duPont Hospital for Children
Wilmington, Delaware · Recruiting
MedStar Georgetown University Hospital
Washington D.C., District of Columbia · Recruiting
Children's National Medical Center
Washington D.C., District of Columbia · Recruiting
Broward Health Medical Center
Fort Lauderdale, Florida · Active not recruiting
Golisano Children's Hospital of Southwest Florida
Fort Myers, Florida · Recruiting
UF Health Cancer Institute - Gainesville
Gainesville, Florida · Recruiting
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, Florida · Recruiting
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida · Recruiting
Palms West Radiation Therapy
Loxahatchee Groves, Florida · Active not recruiting
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida · Recruiting
Nicklaus Children's Hospital
Miami, Florida · Suspended
AdventHealth Orlando
Orlando, Florida · Recruiting
Arnold Palmer Hospital for Children
Orlando, Florida · Recruiting
Nemours Children's Hospital
Orlando, Florida · Recruiting
Showing 40 of 206 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.